About Huamai Tyco
Huamai Tyco is a company based in Beijing (China) founded in 2011 by Jian Zhou. Huamai Tyco has raised $14 million across 1 funding round from investors including General Technology Venture Capital, Everest Ventures Group and Insight Capital. Huamai Tyco operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.
- Headquarter Beijing, China
- Founders Jian Zhou
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14 M (USD)
in 1 rounds
-
Latest Funding Round
$14 M (USD), Series B
Jul 01, 2019
-
Investors
General Technology Venture Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Huamai Tyco
Huamai Tyco has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series B round of $14 million completed in July 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Huamai Tyco
Huamai Tyco has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include General Technology Venture Capital, Everest Ventures Group and Insight Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Fin-tech startups are incubated by the Hong Kong-based studio.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by the venture capital firm.
|
Locked | Locked | Locked |
Investor details for Huamai Tyco
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Huamai Tyco
Investment portfolio details for Huamai Tyco
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Huamai Tyco
Detailed financials for Huamai Tyco
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Huamai Tyco Comparisons
Peer comparison for Huamai Tyco
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Huamai Tyco
Huamai Tyco operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| Locked | Locked | Locked |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| Locked | Locked | Locked |
Venous stent system is developed for deep vein disease treatment.
|
|
| Locked | Locked | Locked |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| Locked | Locked | Locked |
Products for interventional cardiology and critical care procedures
|
|
| Locked | Locked | Locked |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
Detailed competitors of Huamai Tyco
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Huamai Tyco
Complete news archive for Huamai Tyco
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Huamai Tyco
Huamai Tyco was founded in 2011 and raised its 1st funding round 8 years after it was founded.
Huamai Tyco is headquartered in Beijing, China.
Jian Zhou is the current CEO of Huamai Tyco. They have also founded this company.
Huamai Tyco is a funded company, having raised a total of $14M across 1 funding round to date.
Founded in 2011 and based in Beijing, China, the company operates in the medical device sector. An abdominal aortic covering stent system is provided for treating aortic diseases. The system is composed of a main body stent graft, a conveyor, and a leg-mounted stent graft. Development and production activities are centered on these components to address vascular conditions.
Huamai Tyco has 3 investors. Key investors include General Technology Venture Capital, Everest Ventures Group, and Insight Capital.